Psychedelics Today cover image

Psychedelics Today

Latest episodes

undefined
Sep 29, 2023 • 1h 23min

PT446 – Jasmine Virdi & Tabata Gerk – Decolonization, Interconnection, and the Medicalization of Mysticism

In this episode – with the ​2024 edition of Vital​ announced and applications officially open – we’re launching another series of Vital Psychedelic Conversations, with David hosting Jasmine Virdi: Vital instructor, writer, educator, and activist who works at Synergetic Press and volunteers for Fireside Project; and Tabata Gerk: Vital student, psychotherapist, and facilitator. As always, they discuss what they think the most vital conversation should be right now, largely expressing concerns over the medicalization of psychedelics and the idea of a ‘traumadelic culture,’ where psychedelics are often only seen as healers of trauma and not doorways to mysticism and new ideas. And they point out another concern: the romanization of Indigenous culture and not recognizing that these are contemporary cultures that are affected by the same Western, capitalist paradigms that affect us all. They also discuss the concept of epistemic injustice and needing to respect other ways of knowing; hyper-individualism and why we became so reductionist as a society; the role of money (who defines the problem and the solution?); concerns over who decides who is allowed to use these substances; the power of small steps of change; and, through talking about Gerk’s recent Amazonian ayahuasca experience, they dig into what it is about these experiences and surrounding communities that make them so special. Could we take some of that and effectively incorporate it into our Western models? Click here to head to the show notes page. 
undefined
Sep 26, 2023 • 1h 28min

PT445 – Ethan Nadelmann – The Drug War, Harm Reduction, and the Middle Ground Between Liberty and Regulation

In this episode, Joe interviews Ethan Nadelmann: author, speaker, Founder and former Executive Director of Drug Policy Alliance, host of the PSYCHOACTIVE podcast, and one of the leading voices in drug policy reform and harm reduction.  Nadelmann shares his journey from Princeton University to founding Drug Policy Alliance, to working with George Soros, encouraging Gary Johnson to push cannabis legalization, and interacting with prominent figures like Milton Friedman and Grover Norquist. He explores the motivations behind the drug war, the massive growth of incarcerations it led to, why the US spread its war on drugs abroad even when it went against our best interests, and, thankfully, the progress made in fighting the drug war – particularly with cannabis and psychedelics. And he discusses much more: the banning of drug testing kits; the damages of our slow learning curve against the idea of a safe supply; the risks of under-prescribing opioids for people who actually need them; how libertarians, the right, and left are all starting to become against the drug war for the same reasons; why cigarette smokers should all switch to vaping; the concept of needing to pass a test at the pharmacy to prove you understand (and won't abuse) medication; and some strong arguments for decriminalization as an incremental step. And he asks some pretty important questions that we can all simmer on for a bit: how do we find a balance between helping people and not opening the rest of society up to harm? How do we challenge abuse in a way that doesn't hurt future harm reduction efforts? And how do we incentivize people into acting in their own best interests?  Click here to head to the show notes page. 
undefined
Sep 22, 2023 • 1h 23min

PT444 – Melanie Pincus, Ph.D. & Manesh Girn, Ph.D. – A Glimpse Into the Psychedelic Neuroscience Landscape

In this special episode, Melanie Pincus, Ph.D. and Manesh Girn, Ph.D., who joined David in episode 403 to discuss the launch of their new course, essentially interview each other. As the 2nd edition of their popular course, Psychedelic Neuroscience Demystified, begins on November 1, we wanted to give them a chance to highlight some of the aspects of neuroscience students can expect to learn in the course, and what so many people who are interested in psychedelics don’t fully understand: What does neuroplasticity actually entail? Can one predict if a patient is more apt to have an experience with ego dissolution? How does the amygdala relate to mood disorders? When are critical periods of greater plasticity and socialization at their most beneficial? How does neuroplasticity relate to chronic stress? They also discuss lessons they’ve received from their own journeys; why they created the course; serotonin; psychological flexibility; body-based versions of self vs. memory-based versions; psychedelics and re-encoding memories (and the potential for false memories); how psychedelic therapy is different from standard drug treatments; psychedelics and the default mode network (is the story oversimplified?), and much more.  Click here to head to the show notes page. 
undefined
Sep 19, 2023 • 1h 14min

PT443 – Rachel Harris, Ph.D. – Swimming in the Sacred: The Wisdom of Underground Female Elders

In this episode, Kyle interviews Rachel Harris, Ph.D.: Psychologist in private practice for over 40 years, researcher who has published more than 40 peer-reviewed studies, and author of the new book, Swimming in the Sacred: Wisdom from the Psychedelic Underground. She talks about graduating college and going straight to Esalen, where she had little concern over therapy or integration, and how, after 20 years of ayahuasca experiences, she learned to see psychedelic-assisted therapy and ceremonial, transformational experiences as very different things. She discusses her ayahuasca journeys; a surprising MDMA experience; what having an ongoing relationship with the spirit of ayahuasca means; Ann Shulgin’s concerns over going through death’s door while in a journey; what true integration is; how psychedelics can help prepare for death, and more. And she talks about her new book, Swimming in the Sacred, which collects the stories, unique perspectives, and wisdom of 15 female elders who have been working in the underground for at least 15 years each, and how their experience has led to a somatic-based intuition and ‘know it in their bones’ feeling that so many new practitioners and facilitators need – and can only come with time.  Click here to head to the show notes page. 
undefined
Sep 15, 2023 • 1h 5min

PT442 – Joe Moore – Burning Questions About Burning Man: Mud, Ebola, and the Big Krab Car

Joe Moore discusses his experience at Burning Man, including the challenges of preparing for the event, the media's interpretation of the rain and mud, and the debate over the environmental impact. He also talks about the joys of Burning Man, the importance of patience, and his experience DJing on the Big Krab Car. The podcast also explores topics such as theft at Burning Man, open dialogue in psychedelic practices, and the escape of Diplo and Chris Rock from the event.
undefined
Sep 12, 2023 • 43min

PT441 – General Stephen Xenakis – The American Psychedelic Practitioners Association and the Mission to Integrate Psychedelics into U.S. Healthcare

In this episode, Kyle interviews General Stephen Xenakis, MD: an adult, child, and adolescent psychiatrist who retired from the U.S. Army in 1998 at the rank of Brigadier General and began a career starting up medical technology companies and clinical practice to support human rights and new methodologies of healthcare.  In June, he became the new Executive Director of the American Psychedelic Practitioners Association (APPA), whose mission is to bring practitioners together as a community; develop the best training programs and practices; shift to a more patient-centered, integrated model of care; eventually accredit practitioners to practice with legal substances; and overall, help to make these new modalities more mainstream.  He discusses their path to success, which began with their publishing of the first professional practice guidelines for psychedelic-assisted therapy practitioners, and will continue on with ethical guidelines and clinical practice guidelines in the future. And he talks about the idea of a safety net for people who have adverse effects from psychedelic journeys; what clinicians need to know about psychedelics; concerns over accessibility; and the importance of identifying the correct treatments for the correct patients, as each person’s path to healing will likely be drastically different. Click here to head to the show notes page. 
undefined
Sep 8, 2023 • 1h 23min

PT440 – Dr. JoQueta Handy, Ph.D., IMD – Coming Back to Stillness, Microdosing and Adaptogens, and What We Can Learn From Autism

In this episode, David interviews Dr. JoQueta Handy, Ph.D., IMD: speaker, author, educator, Natural Integrative Health Practitioner, and CEO and Chief Visionary of Brilliant Learning, Handy Wellness Center, and Brilliant Blends. She shares childhood memories of growing up on her Grandparents’ farm, where she developed a deep appreciation for nature, staring at the stars, and the beauty in stillness, and how coming back to that stillness has been key in her life and psychedelic journeys. The conversation then shifts to all that she’s learned through her work with children on the autism spectrum: the problems of putting people into boxes; how autism affects everyone; the different ways people learn; the connection between autism and the gut microbiome; and how she has learned more from some of these children than any book could teach her – culminating in a story of discovering that a very challenged child people were ready to give up on could actually read and comprehend everything he was hearing. She discusses her favorite adaptogens; the art of stacking adaptogens and different modalities; her multi-day coaching sessions; Internal Family Systems; quantum biofeedback; the use of supplements in microdosing; and Brilliant Blends, which sells blends of supplements designed to provide benefits as close to what psilocybin can provide (but legally) – inspired by the unique needs of autistic individuals. PT listeners can receive 10% off all purchases with code: PT10. Click here to head to the show notes page. 
undefined
Sep 6, 2023 • 1h 20min

PT439 – Introducing Hyphae Leaks: Not Your Average Psychedelic Podcast

Joe Moore, Mary, and Reggie launch Hyphae Leaks, a podcast aiming to cover provocative topics in the psychedelic world. They discuss conservation, indigeneity, and cannabis legalization on reservations. The episode also explores the media's discrediting of investigative journalism on the drug war, the importance of legalizing psychedelics, and conspiracy theories. The speakers are excited to create valuable content for their audience.
undefined
Sep 5, 2023 • 1h 16min

PT438 – Lynn Marie Morski, MD, JD – The Psychedelic Medicine Association and Managing Medical Risk in Patients Seeking Psilocybin Therapy

In this episode, David interviews the President of the Psychedelic Medicine Association, host of the Psychedelic Medicine Podcast, and Psychedelics Today advisory board member and Vital contributor: Lynn Marie Morski, MD, JD. She shares her journey with psychedelics and how they enabled her to leave a toxic job and pursue her passion for advocacy with vitality, and how important it is to focus your energy where it's best used. She talks about where we find ourselves in the psychedelic space based on Psychedelic Science 2023, as well as her recent TV appearances and the responsibility of preaching to the non-choir. And she discusses the idea of perfectionism in today's age; the need for psychedelic people to be involved in non-psychedelic conferences; the complications behind requiring physicians to experience psychedelics; the concept of it being malpractice for a physician to not mention psychedelic options; and the Psychedelic Medicine Association's upcoming virtual conference: Sana Symposium 2023, which happens October 26-27.  Morski talks a lot about the importance of educating healthcare professionals about psychedelics, debunking myths, and the need for standards in training therapists and primary care providers. She highlights how there is still no nationally-recognized certification for even ketamine providers, so how can people make informed decisions on who to trust? The Psychedelic Medicine Association is taking steps to improve this paradigm, offering a new course called "Managing Medical Risk in Patients Seeking Psilocybin Therapy," which will work to help clinicians make risk assessments for patients seeking psilocybin therapy – something that is not really being done today.  Click here to head to the show notes page.   
undefined
Sep 1, 2023 • 1h 8min

PT437 – Chase Hudson – Exploring Psychedelic Therapies: Iboga, CBD, and Cannabis Paired With Ketamine

Chase Hudson discusses CBD, iboga, and ketamine therapy benefits, Lamar Odom's recovery journey, cannabis as a gateway to healing, need for insurance in psychedelic therapy, and the evolving landscape of psychedelics in Utah. Personal stories of ibogaine treatment and ketamine sessions highlight the power of education to combat drug war propaganda.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app